Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Heng Miao
Efficacy and Safety of Three-Times-Daily Versus Twice-Daily Biphasic Insulin Aspart 30 in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Combined With Oral Antidiabetic Drugs
Diabetes Research and Clinical Practice
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Related publications
Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-On Therapy in Chinese Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Patients With Type 2 Diabetes Inadequately Controlled on Premixed Insulin: Effect of Initiating Insulin Glargine Plus Oral Antidiabetic Agents on Glycaemic Control in Daily Practice*
International Journal of Clinical Practice
Medicine
15 Years of Experience With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Drugs in R and D
Pharmacology
Clinical Study of Treatment Switching From Premixed Insulin to Basal Insulin Combined With Oral Hypoglycemic Drugs in Patients With Type 2 Diabetes
Diabetology and Metabolic Syndrome
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of 1:1 Fixed Ratio Combination of Insulin Glargine/Lixisenatide (iGlarLixi) Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial
Efficacy and Safety of 1:1 Fixed Ratio Combination of Insulin Glargine/Lixisenatide (iGlarLixi) Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial
Understanding Patients With Type 2 Diabetes Mellitus Using Oral Antidiabetic Drugs
Journal of Medicine and Health
Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
The Risk of Severe Hypoglycemia in Patients With Type 2 Diabetes Mellitus Starting Insulin Therapy With Premixed Insulin Analogues Taken Twice Daily: An Observational Study in Turkish Patients
Turkish Journal of Endocrinology and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
